Activation of oxydative metabolism during cardiopulmonary bypass (CPB) with membrane oxygenators.
1989-01-01 Formica, M; Giordano, G; Cavalli, G; Amprimo, Mc; Pignatelli, Mg; Roccatello, D; Ruggero, De Paulis
Pressure indices of myocardial oxygen consumption during pulsatile ventricular assistance
1989-01-01 John, Marks; George M, Pantalos; Jerome B, Riebman; Scott D, Everett; Gregory L, Burns; Nelson A, Burton; Ruggero, De Paulis
Left ventricular oxigen consumption and organ blood flow distribution during pulsatile ventricular assist
1988-01-01 M, Pantalos George; D, Marks John; B, Riebman Jeron; D, Everett Scott; B, Burns Gregory; Ruggero, De Paulis
Heparin-Protamine interaction in blood following CPB.
1988-01-01 Ruggero, De Paulis; Mohammad, Sf; Chiariello, L; Morea, M; Olsen, Db
Hemodynamic and energetic assessment of calves implanted with a left ventricular assist device (LVAD).
1988-01-01 G, Pantalos; J, Marks; Jb, Riebman; N, Burton; Ruggero, De Paulis; Wj, Kolff
Evaluation of thrombogenesis on smooth and rough intima in artificial ventricles
1987-01-01 L, Verhagen Metman; Ruggero, De Paulis; Mohammad, ; F and Kolff, S; J, W
Early preliminary results of a new total artificial heart connector system
1987-01-01 John H, Holfert; Jerome B, Riebman; Pamela A, Dew; Ruggero, De Paulis; Don B, Olsen
Hemodynamic effect of I.V. administration of protamine: elucidation of the mechanism.
1987-01-01 Ruggero, De Paulis; Mohammad, Fs; Deleuze, P; Riebman JR and Olsen, Db.
Total artificial heart (TAH): a better model to study the hemodynamic effect of protamine.
1987-01-01 Ruggero, De Paulis; Mohammad, Fs; Riebman, Jr; Deleuze, P and Olsen DB
EP34 ROLE OF SPECIALIZED CENTRE AND TEAMWORK IN THE DIAGNOSIS OF MARFAN SYNDROME AND PREVENTION OF ACUTE AORTIC DISSECTION
2018-01-01 Fabio, Bertoldo; C, Pisano; P, Nardi; Concettina, Donzelli; Giuseppina, Laganà; B, Salehi; Federica C, Sangiuolo; P, Bollero; F, De Maio; R, Mancino; M, Chiocchi; A, De Stefano; Paola, Cozza; Giovanni, Ruvolo; Giuseppe, Novelli
HDAC4 is necessary for satellite cell differentiation and muscle regeneration
2014-01-01 Marroncelli, N; Novello, C; Silvia, Consalvi; Saccone, V; Puri, Pl; Olson, En; Adamo, S; Moresi, V
Givinostat improves histological and functional parameters in mdx mice dose and concentration dependently
2012-01-01 Silvia, Consalvi; Mozzetta, C; Bettica, P; Mascagni, P; Monzani, P; German, Mi; Del Bene, F; Puri, Pl; Saccone, V
Virological response and resistance in multi-experienced patients treated with raltegravir
2008-01-01 Ceccherini-Silberstein, F; Daniele, Armenia; D'Arrigo, R; Micheli, V; Fabeni, L; Meraviglia, P; Capetti, A; Zaccarelli, M; Trotta, Mp; Narciso, P; Antinori, A; Perno, Cf
Selection and coevolution of mutational patterns in the HIV-1 integrase characterized by pyrosequencing analysis
2009-01-01 Ceccherini-Silberstein, F; Daniele, Armenia; D'Arrigo, R; Vandenbroucke, I; Van Marck, H; Fabeni, L; Cento, V; Van Baelen, K; Rizzardini, G; Lo Caputo, S; Tozzi, V; Narciso, P; Antinori, A; Stuyver, L; Perno, Cf
HIV-1 INTEGRASE MUTATIONS, FOUND AS MINORITY QUASISPECIES IN PATIENTS NAIVE TO INTEGRASE INHIBITORS, ARE ASSOCIATED WITH DECREASED SUSCEPTIBILITY TO RALTEGRAVIR AND ELVITEGRAVIR IN VITRO
2009-01-01 Daniele, Armenia; M, Trignetti; K, Van Baelen; Lavinia, Fabeni; Rd, Arrigo; Michela, Pollicita; F, Scopelliti; V, Van Eygen; E, Rondelez; S, Aquaro; Massimo, Andreoni; Lj, Stuyver; Francesfca, Ceccherini-Silberstein; Carlo Federico, Perno
IMPACT OF MUTATIONS AT POSITION 135 OF HIV-1 REVERSE TRANSCRIPTASE ON VIROLOGIC RESPONSE TO A FIRST LINE NNRTI-CONTAINING HAART
2009-01-01 Svicher, V; Daniele, Armenia; Santoro, Mm; Forbici, F; Bruzzone, B; Setti, M; Corsi, P; Maserati, R; Mussini, C; Zazzi, M; De Luca, A; Andreoni, M; Narcisco, P; Antinori, A; Perno, Cf; Ceccherini-Silberstein, F
Anti-HIV-1 activity of new integrase inhibitors in lymphocytes and human primary macrophages
2009-01-01 Michele, Pollicita; Fernanda, Scopelliti; Francesca, Ceccherini-Silberstein; Daniele, Armenia; S, Aquaro; Carlo Federico, Perno
Darunavir (DRV)/r plus raltegravir (RAL) dual regimen in multi-experienced population: long term efficacy and tolerability
2010-01-01 Amedeo, Capetti; P, Zucchi; Stefania, Piconi; S, Landonio; Christian F, Magni; D, Pocaterra; Valeria, Micheli; Francesca, Ceccherini-Silberstein; S, Rosa; Daniele, Armenia; Carlo Federico, Perno; Giuliano, Rizzardini
Natural raltegravir-resistance is a rare event in integrase-inhibitors naive patients, and when present, is confined to a restricted minority of secondary variants and is not associated with virological response to raltegravir
2010-01-01 Daniele, Armenia; Vandenbroucke, I; Fabeni, L; D'Arrigo, R; Van Baelen, K; Van Marck, H; Micheli, V; Van Wesenbeeck, L; Trotta, Mp; Lo Caputo, S; Bruzzone, B; Capetti, A; Di Perri, G; Narciso, P; Rizzardini, G; Antinori, A; Stuyver, L; Perno, Cf; Ceccherini-Silberstein, F
Impact of baseline HIV-1 integrase polymorphisms on virological outcome in a large European cohort of patients starting a raltegravir-containing regimen
2011-01-01 Daniele, Armenia; Isabelle, Malet; Lavinia, Fabeni; S, Reigadas; V, Guillot; Daniel, Dunn; R, Kaiser; Maurizio, Zazzi; K, Van Laethem; Anna, Artese; C, Garrido; B, Masquelier; Federico, Garcia; V, Calvez; Andrea, Antinori; Ag, Marcelin; Carlo Federico, Perno; A M, Geretti; Francesca, Ceccherini-Silberstein
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activation of oxydative metabolism during cardiopulmonary bypass (CPB) with membrane oxygenators. | 1-gen-1989 | Formica, M; Giordano, G; Cavalli, G; Amprimo, Mc; Pignatelli, Mg; Roccatello, D; Ruggero, De Paulis | |
| Pressure indices of myocardial oxygen consumption during pulsatile ventricular assistance | 1-gen-1989 | John, Marks; George M, Pantalos; Jerome B, Riebman; Scott D, Everett; Gregory L, Burns; Nelson A, Burton; Ruggero, De Paulis | |
| Left ventricular oxigen consumption and organ blood flow distribution during pulsatile ventricular assist | 1-gen-1988 | M, Pantalos George; D, Marks John; B, Riebman Jeron; D, Everett Scott; B, Burns Gregory; Ruggero, De Paulis | |
| Heparin-Protamine interaction in blood following CPB. | 1-gen-1988 | Ruggero, De Paulis; Mohammad, Sf; Chiariello, L; Morea, M; Olsen, Db | |
| Hemodynamic and energetic assessment of calves implanted with a left ventricular assist device (LVAD). | 1-gen-1988 | G, Pantalos; J, Marks; Jb, Riebman; N, Burton; Ruggero, De Paulis; Wj, Kolff | |
| Evaluation of thrombogenesis on smooth and rough intima in artificial ventricles | 1-gen-1987 | L, Verhagen Metman; Ruggero, De Paulis; Mohammad, ; F and Kolff, S; J, W | |
| Early preliminary results of a new total artificial heart connector system | 1-gen-1987 | John H, Holfert; Jerome B, Riebman; Pamela A, Dew; Ruggero, De Paulis; Don B, Olsen | |
| Hemodynamic effect of I.V. administration of protamine: elucidation of the mechanism. | 1-gen-1987 | Ruggero, De Paulis; Mohammad, Fs; Deleuze, P; Riebman JR and Olsen, Db. | |
| Total artificial heart (TAH): a better model to study the hemodynamic effect of protamine. | 1-gen-1987 | Ruggero, De Paulis; Mohammad, Fs; Riebman, Jr; Deleuze, P and Olsen DB | |
| EP34 ROLE OF SPECIALIZED CENTRE AND TEAMWORK IN THE DIAGNOSIS OF MARFAN SYNDROME AND PREVENTION OF ACUTE AORTIC DISSECTION | 1-gen-2018 | Fabio, Bertoldo; C, Pisano; P, Nardi; Concettina, Donzelli; Giuseppina, Laganà; B, Salehi; Federica C, Sangiuolo; P, Bollero; F, De Maio; R, Mancino; M, Chiocchi; A, De Stefano; Paola, Cozza; Giovanni, Ruvolo; Giuseppe, Novelli | |
| HDAC4 is necessary for satellite cell differentiation and muscle regeneration | 1-gen-2014 | Marroncelli, N; Novello, C; Silvia, Consalvi; Saccone, V; Puri, Pl; Olson, En; Adamo, S; Moresi, V | |
| Givinostat improves histological and functional parameters in mdx mice dose and concentration dependently | 1-gen-2012 | Silvia, Consalvi; Mozzetta, C; Bettica, P; Mascagni, P; Monzani, P; German, Mi; Del Bene, F; Puri, Pl; Saccone, V | |
| Virological response and resistance in multi-experienced patients treated with raltegravir | 1-gen-2008 | Ceccherini-Silberstein, F; Daniele, Armenia; D'Arrigo, R; Micheli, V; Fabeni, L; Meraviglia, P; Capetti, A; Zaccarelli, M; Trotta, Mp; Narciso, P; Antinori, A; Perno, Cf | |
| Selection and coevolution of mutational patterns in the HIV-1 integrase characterized by pyrosequencing analysis | 1-gen-2009 | Ceccherini-Silberstein, F; Daniele, Armenia; D'Arrigo, R; Vandenbroucke, I; Van Marck, H; Fabeni, L; Cento, V; Van Baelen, K; Rizzardini, G; Lo Caputo, S; Tozzi, V; Narciso, P; Antinori, A; Stuyver, L; Perno, Cf | |
| HIV-1 INTEGRASE MUTATIONS, FOUND AS MINORITY QUASISPECIES IN PATIENTS NAIVE TO INTEGRASE INHIBITORS, ARE ASSOCIATED WITH DECREASED SUSCEPTIBILITY TO RALTEGRAVIR AND ELVITEGRAVIR IN VITRO | 1-gen-2009 | Daniele, Armenia; M, Trignetti; K, Van Baelen; Lavinia, Fabeni; Rd, Arrigo; Michela, Pollicita; F, Scopelliti; V, Van Eygen; E, Rondelez; S, Aquaro; Massimo, Andreoni; Lj, Stuyver; Francesfca, Ceccherini-Silberstein; Carlo Federico, Perno | |
| IMPACT OF MUTATIONS AT POSITION 135 OF HIV-1 REVERSE TRANSCRIPTASE ON VIROLOGIC RESPONSE TO A FIRST LINE NNRTI-CONTAINING HAART | 1-gen-2009 | Svicher, V; Daniele, Armenia; Santoro, Mm; Forbici, F; Bruzzone, B; Setti, M; Corsi, P; Maserati, R; Mussini, C; Zazzi, M; De Luca, A; Andreoni, M; Narcisco, P; Antinori, A; Perno, Cf; Ceccherini-Silberstein, F | |
| Anti-HIV-1 activity of new integrase inhibitors in lymphocytes and human primary macrophages | 1-gen-2009 | Michele, Pollicita; Fernanda, Scopelliti; Francesca, Ceccherini-Silberstein; Daniele, Armenia; S, Aquaro; Carlo Federico, Perno | |
| Darunavir (DRV)/r plus raltegravir (RAL) dual regimen in multi-experienced population: long term efficacy and tolerability | 1-gen-2010 | Amedeo, Capetti; P, Zucchi; Stefania, Piconi; S, Landonio; Christian F, Magni; D, Pocaterra; Valeria, Micheli; Francesca, Ceccherini-Silberstein; S, Rosa; Daniele, Armenia; Carlo Federico, Perno; Giuliano, Rizzardini | |
| Natural raltegravir-resistance is a rare event in integrase-inhibitors naive patients, and when present, is confined to a restricted minority of secondary variants and is not associated with virological response to raltegravir | 1-gen-2010 | Daniele, Armenia; Vandenbroucke, I; Fabeni, L; D'Arrigo, R; Van Baelen, K; Van Marck, H; Micheli, V; Van Wesenbeeck, L; Trotta, Mp; Lo Caputo, S; Bruzzone, B; Capetti, A; Di Perri, G; Narciso, P; Rizzardini, G; Antinori, A; Stuyver, L; Perno, Cf; Ceccherini-Silberstein, F | |
| Impact of baseline HIV-1 integrase polymorphisms on virological outcome in a large European cohort of patients starting a raltegravir-containing regimen | 1-gen-2011 | Daniele, Armenia; Isabelle, Malet; Lavinia, Fabeni; S, Reigadas; V, Guillot; Daniel, Dunn; R, Kaiser; Maurizio, Zazzi; K, Van Laethem; Anna, Artese; C, Garrido; B, Masquelier; Federico, Garcia; V, Calvez; Andrea, Antinori; Ag, Marcelin; Carlo Federico, Perno; A M, Geretti; Francesca, Ceccherini-Silberstein |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista141
Data di pubblicazione
- 2020 - 202418
- 2010 - 201939
- 2000 - 200948
- 1990 - 199926
- 1987 - 198910
Rivista
- CARDIOLOGIA12
- EUROPEAN JOURNAL OF PUBLIC HEALTH12
- JOURNAL OF SLEEP RESEARCH10
- ASAIO TRANSACTIONS8
- INFECTION7
- ITALIAN HEART JOURNAL. SUPPLEMENT7
- EUROPEAN JOURNAL OF TRANSLATIONAL...6
- GASTROENTEROLOGY5
- HELICOBACTER5
- SLEEP MEDICINE5
Keyword
- sleep9
- EEG5
- adolescence3
- dreaming3
- sleep onset3
- EEG topography2
- K-complex2
- misperception insomnia2
- NREM sleep2
- parasomnia2
Lingua
- eng75
- ita11
Accesso al fulltext
- no fulltext126
- open13
- reserved2